Screening, selection and development of an oligonucleotide therapy for the treatment of Myotonic Dystrophy type 1 | RVO.nl | Rijksdienst

Service menu right

Screening, selection and development of an oligonucleotide therapy for the treatment of Myotonic Dystrophy type 1